balance equationreview2017-09-29
Difference 254885000 exceeds tolerance 2533554.000. Presentation or filing-vintage differences need review.
Revenue
$1.35B
Fiscal year ended 2025-09-26Operating income
$264.96M
Fiscal year ended 2025-09-26Free cash flow
$435.85M
Fiscal year ended 2025-09-26Dolby Laboratories, Inc. (DLB) reported revenue of $1.35B and net income of $255.02M for the fiscal year ended 2025-09-26. This page shows 10 annual periods of income statement, balance sheet and cash flow figures normalized from Dolby Laboratories, Inc.’s SEC filings, each linked to the filing it came from. It is classified by the SEC under Patent Owners & Lessors.
Income
| Metric | 2025-09-26 | 2024-09-27 | 2023-09-29 | 2022-09-30 | 2021-09-24 | 2020-09-25 | 2019-09-27 | 2018-09-28 | 2017-09-29 | 2016-09-30 |
|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $1.35B | $1.27B | $1.30B | $1.25B | $1.28B | $1.16B | $1.24B | $1.05B | $1.08B | $1.03B |
| Cost of revenue | $160.13M | $140.50M | $152.57M | $141.36M | $130.02M | $146.50M | $160.85M | $127.56M | $118.53M | $108.98M |
| Gross profit | $1.19B | $1.13B | $1.15B | $1.11B | $1.15B | $1.02B | $1.08B | $927.04M | $961.65M | $916.76M |
| Operating income | $264.96M | $258.33M | $215.75M | $206.60M | $344.39M | $218.74M | $257.08M | $183.50M | $247.13M | $231.80M |
| Net income | $255.02M | $261.82M | $200.66M | $184.09M | $310.23M | $231.36M | $255.15M | $41.75M | $206.48M | $185.86M |
| Research & development | $261.79M | $263.66M | $271.52M | $261.17M | $253.64M | $239.04M | $237.87M | $236.79M | $233.31M | $219.61M |
| Weighted-average diluted shares | shares 97.48M | shares 97.32M | shares 97.73M | shares 101.98M | shares 104.62M | shares 102.94M | shares 104.57M | shares 106.98M | shares 103.29M | shares 102.42M |
| Pretax income | $303.48M | $312.48M | $250.05M | $215.28M | $354.51M | $239.72M | $282.31M | $196.37M | $255.14M | $235.90M |
| Income tax expense | $46.99M | $48.16M | $48.41M | $31.38M | $36.69M | $8.10M | $26.80M | $154.07M | $48.04M | $49.50M |
| Diluted EPS | $2.62 | $2.69 | $2.05 | $1.81 | $2.97 | $2.25 | $2.44 | $0.39 | $2.00 | $1.81 |
| Selling, general & administrative | $647.24M | $604.85M | $612.84M | $634.03M | $556.83M | $555.69M | $549.26M | $507.18M | $468.35M | $464.12M |
| General & administrative | $286.53M | $270.39M | $258.48M | $275.32M | $224.16M | $219.75M | $205.42M | $197.42M | $171.69M | $168.85M |
| Selling & marketing | $360.71M | $334.46M | $354.36M | $358.72M | $332.67M | $335.93M | $343.84M | $309.76M | $296.66M | $295.27M |
Balance
| Metric | 2025-09-26 | 2024-09-27 | 2023-09-29 | 2022-09-30 | 2021-09-24 | 2020-09-25 | 2019-09-27 | 2018-09-28 | 2017-09-29 | 2016-09-30 |
|---|---|---|---|---|---|---|---|---|---|---|
| Cash & equivalents | $701.89M | $482.05M | $745.36M | $620.13M | $1.23B | $1.07B | $797.21M | $918.06M | $634.37M | $519.76M |
| Total assets | $3.23B | $3.11B | $2.98B | $2.69B | $3.11B | $2.92B | $2.82B | $2.87B | $2.53B | $2.31B |
| Current assets | $1.39B | $1.19B | $1.49B | $1.31B | $1.76B | $1.55B | $1.38B | $1.50B | $1.01B | $759.73M |
| Total liabilities | $595.81M | $623.04M | $607.58M | $438.53M | $501.46M | $478.92M | $508.72M | $494.88M | $389.71M | $331.37M |
| Current liabilities | $437.79M | $417.84M | $422.23M | $277.52M | $315.72M | $267.11M | $306.85M | $285.20M | $245.77M | $213.08M |
| Total equity incl. NCI | $2.63B | $2.49B | $2.37B | $2.25B | $2.60B | $2.44B | $2.31B | $2.37B | $2.40B | $2.23B |
| Temporary (mezzanine) equity | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable |
| Inventory | $30.42M | $33.73M | $35.62M | $23.55M | $10.96M | $25.55M | $32.33M | $26.21M | $25.05M | $16.35M |
| Accounts receivable | $331.10M | $315.46M | $262.24M | $243.59M | $232.61M | $180.34M | $189.12M | $166.13M | $73.75M | $75.69M |
| Goodwill | $529.90M | $533.21M | $408.41M | $365.15M | $340.69M | $336.94M | $334.83M | $327.98M | $311.09M | $309.62M |
| Long-term debt | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable |
| Accounts payable | $17.84M | $17.38M | $20.92M | $14.17M | $17.78M | $12.62M | $15.21M | $21.92M | $14.37M | $17.54M |
Cash flow
| Metric | 2025-09-26 | 2024-09-27 | 2023-09-29 | 2022-09-30 | 2021-09-24 | 2020-09-25 | 2019-09-27 | 2018-09-28 | 2017-09-29 | 2016-09-30 |
|---|---|---|---|---|---|---|---|---|---|---|
| Operating cash flow | $472.20M | $327.25M | $367.08M | $318.58M | $447.75M | $343.85M | $327.67M | $352.20M | $377.79M | $360.06M |
| Capital expenditures | $36.35M | $30.01M | $30.34M | $47.93M | $54.45M | $66.35M | $96.28M | $72.81M | $99.62M | $100.76M |
| Investing cash flow | -$10.59M | -$286.29M | $54.21M | -$295.94M | -$44.90M | $134.37M | -$56.23M | $78.09M | -$158.03M | -$282.50M |
| Financing cash flow | -$247.24M | -$287.81M | -$236.81M | -$610.56M | -$252.52M | -$207.78M | -$385.28M | -$133.63M | -$106.83M | -$91.99M |
| Net change in cash | $215.61M | -$240.21M | $189.60M | -$604.66M | $153.05M | $274.39M | -$119.66M | $290.88M | $110.90M | -$15.81M |
| Stock-based compensation | $128.51M | $119.82M | $118.49M | $114.92M | $99.70M | $86.63M | $76.58M | $71.25M | $65.34M | $66.98M |
| Common dividends paid | $126.60M | $114.58M | $103.41M | $100.07M | $89.17M | $88.58M | $77.50M | $66.16M | $57.06M | $48.40M |
| Common share repurchases | $124.99M | $160.00M | $149.28M | $530.49M | $245.86M | $173.74M | $340.58M | $150.47M | $100.00M | $100.85M |
| Depreciation & amortization | $87.83M | $75.56M | $82.56M | $88.46M | $95.86M | $90.88M | $85.12M | $81.28M | $84.31M | $85.15M |
Derived
| Metric | 2025-09-26 | 2024-09-27 | 2023-09-29 | 2022-09-30 | 2021-09-24 | 2020-09-25 | 2019-09-27 | 2018-09-28 | 2017-09-29 | 2016-09-30 |
|---|---|---|---|---|---|---|---|---|---|---|
| Free cash flow | $435.85M | $297.24M | $336.74M | $270.65M | $393.30M | $277.50M | $231.39M | $279.39M | $278.18M | $259.30M |
| Gross margin | 88.1% | 89.0% | 88.3% | 88.7% | 89.9% | 87.4% | 87.0% | 87.9% | 89.0% | 89.4% |
| Operating margin | 19.6% | 20.3% | 16.6% | 16.5% | 26.9% | 18.8% | 20.7% | 17.4% | 22.9% | 22.6% |
| FCF margin | 32.3% | 23.3% | 25.9% | 21.6% | 30.7% | 23.9% | 18.6% | 26.5% | 25.8% | 25.3% |
| SBC / revenue | 9.5% | 9.4% | 9.1% | 9.2% | 7.8% | 7.5% | 6.2% | 6.8% | 6.0% | 6.5% |
| Current ratio | 3.17x | 2.86x | 3.52x | 4.72x | 5.58x | 5.79x | 4.50x | 5.25x | 4.12x | 3.57x |
| Revenue YoY growth | 5.9% | -2.0% | 3.7% | -2.1% | 10.3% | -6.4% | 17.7% | -2.4% | 5.3% | Unavailable |
| Net margin | 18.9% | 20.6% | 15.4% | 14.7% | 24.2% | 19.9% | 20.5% | 4.0% | 19.1% | 18.1% |
| R&D / revenue | 19.4% | 20.7% | 20.9% | 20.8% | 19.8% | 20.6% | 19.2% | 22.5% | 21.6% | 21.4% |
| CapEx / revenue | 2.7% | 2.4% | 2.3% | 3.8% | 4.3% | 5.7% | 7.8% | 6.9% | 9.2% | 9.8% |
| Long-term debt / equity | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable |
| Effective tax rate | 15.5% | 15.4% | 19.4% | 14.6% | 10.3% | 3.4% | 9.5% | 78.5% | 18.8% | 21.0% |
Amounts are abbreviated; the exact reported value is carried in each cell. — means unavailable, not zero. Open DLB in the interactive workspace to inspect any figure back to its filing.
Source filings
10-Q · Filed 2026-07-30View SEC filing
10-Q · Filed 2026-04-30View SEC filing
10-Q · Filed 2026-01-29View SEC filing
10-K · Filed 2025-11-18View SEC filing
10-Q · Filed 2025-07-31View SEC filing
10-Q · Filed 2025-05-01View SEC filing
Reconciliation checks needing review
2 periods on this page do not reconcile under this site’s normalization. Read that as a limitation here before an observation about the company: the figures are the filer’s own, the filings linked above are authoritative, and a difference usually means the concepts this site selected do not match how this filer presents its statements. Nothing is adjusted to make a check pass.
balance equationreview2016-09-30
Difference 250206000 exceeds tolerance 2310106.000. Presentation or filing-vintage differences need review.